FindTrial
Sign In

Using tissue samples to help diagnose and predict the outcome of blood cancer using a machine that analyzes cell charecteristics

Utility of Flow cytometry in diagnosis and prognosis of Lymphomas from tissue samples - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/058112
Enrollment
40
Registered
2023-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue

Interventions

Intervention1: NIL: NIL

Sponsors

Dr Abhishek Tiwari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Suspected case of lymphoma 2.With with generalised and/or localised lymphadenopathy 3. Treatment naïve 4. Age 1-80 years

Exclusion criteria

Exclusion criteria: 1. Relapsed or partially treated Lymphoma 2. Excisional biopsy not possible or feasible 3. Lymphoma 80 years

Design outcomes

Primary

MeasureTime frame
To compare flow cytometry with immunohistochemistry(IHC) findings by calculating the: 1. Overall concordance rate, 2. Sensitivity and 3. Specificity.Timepoint: At the end of the study.—

Secondary

MeasureTime frame
1. To calculate the turn around time between flow cytometry and immunohistochemistry. 2. To co-relate FCI and histopathological findings with established poor prognostic factors.Timepoint: At the end of the study.—

Countries

India

Contacts

Public ContactDr Soumya Surath Panda

Institute of Medical Sciences and SUM Hospital, SOA

ssp_scb@yahoo.com8895370579

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026